单细胞转录基因签名分析确定IL-17信号通路是败血症的关键通路
Huayan Zhao1, Yuanzhe Li2, Guiying Sun3
1Department of Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Immunobiology
|December 1, 2023
概括
败血症是一种严重的炎症状况,涉及免疫细胞中的IL-17信号通路. 这一途径为败血症治疗和诊断提供了一个有前途的治疗标.
科学领域:
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
- 系统生物学 系统生物学
背景情况:
- 败血症是一种危及生命的全身性炎症反应,死亡率高.
- 确定关键的分子通路对于开发有效的败血症生物标志物和治疗方法至关重要.
研究的目的:
- 确定与败血症严重程度和患者结果相关的关键途径.
- 探索潜在的诊断生物标志物和败血症的治疗点.
主要方法:
- 分析了来自败血症患者和健康对照组的单细胞和大量RNA测序数据.
- 使用了t-SNE,UMAP,基因本体学 (GO) 和KEGG路径分析.
- 使用细胞标记数据库和R包注释识别的细胞类型.
主要成果:
- 在败血症外周血液单核细胞 (PBMC) 中发现了18个不同的细胞群.
- 在单细胞,NK细胞和T细胞中发现了IL-17信号通路的显著丰富.
- 在败血症血液样本中确认了IL-17通路相关基因的上调.
结论:
- IL-17信号通路是败血症发展的一个重要机制.
- 这一途径为败血症治疗提供了一个有前途的治疗标.
- 这些发现增强了对败血症病理生理学的理解.
相关概念视频
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K


